Kyverna Therapeutics ($KYTX)

Overview

Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and generalized myasthenia gravis.

Part of the Silicon Valley ecosystem

Related

• 8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
• ARCH Venture PartnersBuilds and backs science-based companies, investing flexibly in portfolio businesses founded around technologies intended to affect human health and disease.
• CellaresDevelops and operates automated cell therapy manufacturing technologies and services, helping therapy developers transfer production and analytical processes into cGMP-compliant systems.
• Chai DiscoveryBuilds computer-aided molecular design software that models biochemical structure and interaction, helping scientists design new medicines and molecules on computers.
• In-Q-TelBuilds a nonprofit investment platform that identifies strategic technology startups and adapts their technologies to meet current and future government partner mission needs.
• IndieBioProvides onsite biolabs and pre-seed investment for scientists launching startups across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics.
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics across multiple drug modalities.
• NewLimitDevelops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related cellular decline and human healthspan.
• ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design applications.
• Scribe TherapeuticsEngineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and collaborations extending the approach to other therapeutic areas.
• Stanford UniversityEducates students, conducts interdisciplinary research, develops technologies, supports human health, and applies policy work to address societal needs and benefit humanity.
• SynBioBeta (Synthetic Biology Summit)Hosts an annual synthetic biology summit with conference sessions, speakers, passes, and exhibit hall participation for biotech attendees, companies, sponsors, and exhibitors.